<?xml version="1.0" encoding="UTF-8"?>
<p class="p">Vero cells (ATCC: CCL 81TM, UK; were gained from MUH, Prague, Czech Republic) were grown and prepared as previously described [
 <xref rid="B31-jcm-07-00283" ref-type="bibr" class="xref">31</xref>]. A clinical isolate of HSV-2 (obtained from HSV-2 infected patients) was kindly acquired from MUH, Prague, Czech Republic. The clinical strain was typed, identified, propagated in Vero cells, and the titers, which are expressed as 50% tissue culture infective dose (TCID
 <sub class="sub">50</sub>/mL), were assayed by cytopathic end-point method following the same procedures by Hassan et al. [
 <xref rid="B31-jcm-07-00283" ref-type="bibr" class="xref">31</xref>]. Viral stocks were stored at −80 °C.
</p>
